跳至主要内容
临床试验/NCT01789307
NCT01789307已完成不适用

Lactose: A Unique Carbohydrate Enabling Homeostatic Regulation of Blood Glucose & Insulin

University of British Columbia2 个研究点 分布在 1 个国家目标入组 16 人开始时间: 2013年1月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
16
试验地点
2
主要终点
Postprandial changes in plasma insulin, glucagon, triglycerides and amino acids.

研究概览

简要总结

Lactose, one of the key nutrients in human milk may be critically important to infants for more reasons than being a source of energy. We are interested in understanding how lactose when compared to other sugars influences how nutrients, specifically macronutrients are handled after digestion and absorption. To date, there have been no studies looking at how fat and protein varies when lactose compared to other sugars is ingested. There may be metabolic advantages to considering lactose for nutrition support of premature infants rather than glucose or dextrose as is often used in intravenous feeds, or the corn syrup solids in lactose-free formulas. We hope the information from this study will provide new information on the unique aspects of lactose.

Hypothesis: The hypothesis is that providing carbohydrate as lactose:

  1. minimizes the amount of carbohydrate that is converted into fat
  2. enables a relatively constant metabolic state throughout feeding interval that avoids swings of high to low insulin, glucose, and fats.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Other
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
19 Years 至 60 Years(Adult)
性别
Male
接受健康志愿者

入选标准

  • at least 19 years of age
  • body mass index (BMI) between 18.5 and 25
  • fasting blood glucose level < 6.1 mmol/L (110 mg/dL) measured by glucometer on the day of the study and
  • comfortable speaking, reading and understanding English
  • comfortable drinking at least one cup (250 ml) of milk
  • non-smoking

排除标准

  • not willing to provide blood samples, have
  • impaired lactose or glucose tolerance,
  • pre-diabetes, diabetes mellitus and any other endocrine disorder,
  • coronary heart disease, liver function test abnormalities or any chronic disease
  • routinely take medications, including aspirin, cyclooxygenase-2 inhibitors, statins and fish oil
  • consuming more than 1 alcoholic drink per day

研究组 & 干预措施

corn syrup solids

Active Comparator

corn syrup solids oral ingestion

干预措施: corn syrup solids (Dietary Supplement)

sucrose

Experimental

sucrose oral ingestion

干预措施: sucrose (Dietary Supplement)

结局指标

主要结局

Postprandial changes in plasma insulin, glucagon, triglycerides and amino acids.

时间窗: 6 hours

Area under the curve changes in the outcome measures following oral ingestion.

次要结局

  • Postprandial changes in plasma fatty acids.(6 hours)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验